Danaher (DHR) Total Non-Current Liabilities (2009 - 2026)
Danaher (DHR) posted Total Non-Current Liabilities of $33.3 billion for Q2 2026, up 32.9% on a QoQ basis from $25.0 billion in Q1 2026, and up 40.63% year-over-year from $23.6 billion in Q2 2025.
Analysis
Danaher (DHR) Total Non-Current Liabilities (2009 - 2026) Analysis & Trends
Danaher has reported Total Non-Current Liabilities for 18 years, with the latest figure at $33.3 billion in Q2 2026.
- On a quarterly basis, Total Non-Current Liabilities rose 40.63% year-over-year to $33.3 billion in Q2 2026; TTM through Jun 2026 was $33.3 billion, a 40.63% increase from a year earlier, with the FY2025 full-year figure at $25.2 billion, up 13.12% from the prior year.
- Total Non-Current Liabilities was $33.3 billion for Q2 2026 at Danaher, up from $25.0 billion in the prior quarter.
- The five-year high for Total Non-Current Liabilities was $33.3 billion in Q2 2026, with the low at $22.3 billion in Q4 2024.
- Average Total Non-Current Liabilities over 5 years is $25.8 billion, with a median of $25.1 billion recorded in 2025.
- The sharpest annual moves came in 2024 and 2026: Total Non-Current Liabilities retreated 18.06% in 2024, then surged 40.63% in 2026.
- Over 5 years, Total Non-Current Liabilities stood at $27.8 billion in 2022, then slipped by 10.02% to $25.0 billion in 2023, then retreated by 10.74% to $22.3 billion in 2024, then gained by 13.12% to $25.2 billion in 2025, then soared by 31.83% to $33.3 billion in 2026.
- The last three Total Non-Current Liabilities figures came in at $33.3 billion (Q2 2026), $25.0 billion (Q1 2026), and $25.2 billion (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 241.68 Bn | 237.61 Bn | 8.34 Bn | 55.95 Bn |
| 2 | Danaher | 147.34 Bn | 142.99 Bn | 3.61 Bn | 33.25 Bn |
| 3 | Agilent Technologies | 43.34 Bn | 41.59 Bn | 1.04 Bn | 6.06 Bn |
| 4 | Illumina | 34.58 Bn | 33.41 Bn | 770.00 Mn | 3.52 Bn |
| 5 | Revvity | 16.31 Bn | 15.29 Bn | 416.87 Mn | 4.05 Bn |
| 6 | Bio-Techne | 11.28 Bn | 11.01 Bn | 211.39 Mn | 457.16 Mn |
| 7 | Bio-Rad Laboratories | 10.16 Bn | 8.54 Bn | 345.80 Mn | 2.88 Bn |
| 8 | Repligen | 9.77 Bn | 8.75 Bn | 110.04 Mn | 821.06 Mn |
| 9 | 10x Genomics | 9.45 Bn | 8.90 Bn | 112.50 Mn | 197.96 Mn |
| 10 | Bruker | 9.26 Bn | 9.04 Bn | 416.00 Mn | 3.06 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 26, 2026 | 33.25 Bn |
| Mar 27, 2026 | 25.02 Bn |
| Dec 31, 2025 | 25.22 Bn |
| Sep 26, 2025 | 23.16 Bn |
| Jun 27, 2025 | 23.65 Bn |
| Mar 28, 2025 | 22.62 Bn |
| Dec 31, 2024 | 22.30 Bn |
| Sep 27, 2024 | 23.66 Bn |
| Jun 28, 2024 | 23.01 Bn |
| Mar 29, 2024 | 24.20 Bn |
| Dec 31, 2023 | 24.98 Bn |
| Sep 29, 2023 | 28.88 Bn |
| Jun 30, 2023 | 26.69 Bn |
| Mar 31, 2023 | 26.99 Bn |
| Dec 31, 2022 | 27.76 Bn |
| Sep 30, 2022 | 26.54 Bn |
| Jul 1, 2022 | 27.61 Bn |
| Apr 1, 2022 | 29.32 Bn |
| Dec 31, 2021 | 30.31 Bn |
| Oct 1, 2021 | 30.85 Bn |